Use of Immune Checkpoint Inhibitors in Refractory Mycosis Fungoides and Sézary Syndrome: A Systematic Review

被引：0
|
作者：
Rijal, Hibo [1 ]
Moustaqim-Barrette, Amina [2 ]
Martinez Villarreal, Amelia [3 ]
Litvinov, Ivan V. [3 ,4 ]
机构：
[1] Queens Univ, Sch Med, Kingston, ON, Canada
[2] McGill Univ, Fac Med, Montreal, PQ, Canada
[3] McGill Univ Hlth Ctr, Div Dermatol, 1001 Decarie Vlvd,Rm E02-6236, Montreal, PQ H4A 3J1, Canada
[4] McGill Univ, Div Dermatol, Montreal, PQ, Canada
来源：
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY | 2025年 / 29卷 / 02期
关键词：
cutaneous T-cell lymphomas; mycosis fungoides; S & eacute; zary syndrome; immune checkpoint inhibitor; treatment; therapeutic; systematic review;
D O I：
10.1177/12034754241290816
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：179 / 180
页数：2
相关论文
共 50 条
  • [1] Mycosis Fungoides and Sézary Syndrome: Updates and Review of Current Therapy
    Hiroaki Kamijo
    Tomomitsu Miyagaki
    Current Treatment Options in Oncology, 2021, 22
  • [2] Systemic treatments with monoclonal antibodies in mycosis fungoides and Sézary syndrome
    Ibatici, Adalberto
    Angelucci, Emanuele
    Massone, Cesare
    DERMATOLOGY REPORTS, 2024, 16
  • [3] Management of Mycosis Fungoides and Sézary Syndrome With Oral Systemic Therapies
    Greenzaid, Jonathan D.
    Thakker, Sach
    Ruley, Ainsley J.
    Eichinger, Justin M.
    Strowd, Lindsay C.
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2025,
  • [4] Insights into treatment of patients with mycosis fungoides or Sézary syndrome using mogamulizumab
    Foss, Francine
    Kim, Youn H.
    Scarisbrick, Julia
    Akilov, Oleg
    Ristuccia, Robert
    Dwyer, Karen
    Wu, Wende
    Bagot, Martine
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2025, 36 (01)
  • [5] On the Way to Curing Advanced-Stage Mycosis Fungoides/Sézary Syndrome
    Purnak, Seda
    Hosing, Chitra
    Dabaja, Bouthaina
    Bassett, Roland L.
    Huen, Auris
    Duvic, Madeleine
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (12): : 827 - 836
  • [6] Regulatory T cells and immunodeficiency in mycosis fungoides and Sézary syndrome
    T Krejsgaard
    N Odum
    C Geisler
    M A Wasik
    A Woetmann
    Leukemia, 2012, 26 : 424 - 432
  • [7] Advancements in the treatment of mycosis fungoides and Sézary syndrome: monoclonal antibodies, immunotherapies, and Janus kinase inhibitors
    Quadri, Iman
    Reneau, John C.
    Hanel, Walter
    Chung, Catherine G.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [8] Analysis of the IL-31 pathway in Mycosis fungoides and Sézary syndrome
    Markus Möbs
    Stefanie Gryzik
    Ahmed Haidar
    Daniel Humme
    Marc Beyer
    Staffan Vandersee
    Archives of Dermatological Research, 2015, 307 : 479 - 485
  • [9] Systemic Treatment Options for Advanced-Stage Mycosis Fungoides and Sézary Syndrome
    Louise Photiou
    Carrie van der Weyden
    Christopher McCormack
    H. Miles Prince
    Current Oncology Reports, 2018, 20
  • [10] Assessing Health-Related Quality of Life in Mycosis Fungoides and Sézary Syndrome: Unmet Needs
    Brazel, Danielle
    Larocca, Cecilia
    Shinohara, Michi M.
    CANCERS, 2024, 16 (15)
12345